Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Twist Bioscience Corp
(NQ:
TWST
)
31.64
-0.32 (-0.99%)
Streaming Delayed Price
Updated: 11:58 AM EDT, May 2, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Twist Bioscience Corp
< Previous
1
2
...
6
7
8
9
10
11
12
13
Next >
Bragar Eagel & Squire, P.C. Is Investigating Veru, Twist, and Leidos and Encourages Investors to Contact the Firm
December 02, 2022
From
Bragar Eagel & Squire
Via
GlobeNewswire
5 Stock Picks For November From Benzinga's Most Accurate Analysts
December 01, 2022
Wall Street analysts make new stock picks on a daily basis. Unfortunately for investors, not all analysts have particularly impressive track records at predicting market movements. Even when it comes...
Via
Benzinga
Wall Street's Analyst Just Said On Dell Technologies; Here Are Other Picks For Last Week From Top Analysts
November 28, 2022
Wall Street analysts make new stock picks on a daily basis. Unfortunately for investors, not all analysts have particularly impressive track records at predicting market movements. Even when it comes...
Via
Benzinga
Bragar Eagel & Squire, P.C. Is Investigating Veru, Twist, Leidos, and DLocal and Encourages Investors to Contact the Firm
November 27, 2022
From
Bragar Eagel & Squire
Via
GlobeNewswire
4 Analysts Have This to Say About Twist Bioscience
November 21, 2022
Via
Benzinga
Twist Bioscience to Present at 5th Annual Evercore ISI HealthCONx Conference
November 23, 2022
From
Twist Bioscience Corporation
Via
Business Wire
Bragar Eagel & Squire, P.C. Is Investigating Fox, Instil, Veru, and Twist and Encourages Investors to Contact the Firm
November 21, 2022
From
Bragar Eagel & Squire
Via
GlobeNewswire
NIO To Surge Around 105%? Plus Keybanc Predicts $165 For This Stock
November 21, 2022
Keybanc raised the price target on AMETEK, Inc. (NYSE: AME) from $145 to $165. Keybanc analyst Steve Barger maintained an Overweight rating on the stock. AMETEK shares rose 0.9% to close at $139.32 on...
Via
Benzinga
Why Twist Bioscience Stock Is Crashing This Week
November 17, 2022
Investors were spooked by a short-seller's allegations.
Via
The Motley Fool
Twist Bioscience's Earnings: A Preview
November 17, 2022
Via
Benzinga
Why Is Twist Bioscience (TWST) Stock Down 18% Today?
November 15, 2022
TWST stock is cratering after a short seller issued a report with a startling target price and alarming accusations.
Via
InvestorPlace
ConocoPhillips To Plunge Over 11%? Plus This Analyst Slashes PT On LiveOne By 25%
November 21, 2022
Societe Generale boosted the price target on ConocoPhillips (NYSE: COP) from $106 to $114. ConocoPhillips shares fell 2% to close at $128.59 on Friday.
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
November 18, 2022
Via
Benzinga
Twist Bioscience Reports Fiscal Fourth Quarter and Full Year Fiscal 2022 Financial Results
November 18, 2022
From
Twist Bioscience Corporation
Via
Business Wire
Earnings Scheduled For November 18, 2022
November 18, 2022
Companies Reporting Before The Bell • So-Young Intl (NASDAQ:SY) is estimated to report quarterly earnings at $0.14 per share on revenue of $62.46 million.
Via
Benzinga
TWIST ALERT: Bragar Eagel & Squire, P.C. is Investigating Twist Bioscience Corp on Behalf of Twist Stockholders and Encourages Investors to Contact the Firm
November 16, 2022
From
Bragar Eagel & Squire, P.C.
Via
Business Wire
ONGOING INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Twist Bioscience Corporation and Encourages Investors with Losses to Contact the Firm
November 16, 2022
From
The Schall Law Firm
Via
Business Wire
Why Shares of Twist Bioscience Fell 19.92% on Tuesday
November 15, 2022
A negative report by a short-seller drove the biotech's shares downward.
Via
The Motley Fool
Twist Bioscience Addresses Misleading Short-Seller Report
November 15, 2022
From
Twist Bioscience Corporation
Via
Business Wire
Why Fast Radius Shares Plunged Around 48%; Here Are 103 Biggest Movers From Yesterday
November 16, 2022
Gainers Satixfy Communications Ltd. (NYSE: SATX) shares gained 140.7% to settle at $31.80 on Tuesday.
Via
Benzinga
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Twist Bioscience Corporation (TWST) on Behalf of Investors
November 15, 2022
From
Glancy Prongay & Murray LLP
Via
Business Wire
INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Twist Bioscience Corporation (TWST) on Behalf of Investors
November 15, 2022
From
Law Offices of Howard G. Smith
Via
Business Wire
The Law Offices of Frank R. Cruz Announces Investigation of Twist Bioscience Corporation (TWST) on Behalf of Investors
November 15, 2022
From
The Law Offices of Frank R. Cruz
Via
Business Wire
Why Opiant Pharmaceuticals Shares Are Trading Higher By 115%? Here Are 67 Stocks Moving In Tuesday's Mid-Day Session
November 15, 2022
Gainers SenesTech, Inc. (NASDAQ: SNES) shares surged 91.7% to $0.2751. SenesTech reported a 1-for-20 reverse stock split.
Via
Benzinga
Why Are Chinese EV Stocks NIO, LI, XPEV Up Today?
November 15, 2022
Chinese EV stocks are on the move Tuesday as investors react to news of a meeting between President Joe Biden and President Xi Jinping.
Via
InvestorPlace
Vodafone, Getty Images Holdings, Haynes International And Some Other Big Stocks Moving Lower On Tuesday
November 15, 2022
U.S. stocks traded higher, with the Nasdaq gaining more than 200 points on Tuesday. Here are some big stocks recording losses in today’s session.
Via
Benzinga
INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Twist Bioscience Corporation and Encourages Investors with Losses to Contact the Firm
November 15, 2022
From
The Schall Law Firm
Via
Business Wire
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
November 15, 2022
Gainers Azenta (NASDAQ:AZTA) shares rose 32.5% to $61.74 during Tuesday's pre-market session. The company's market cap stands at $4.6 billion. As per the news, the Q4 earnings report came out...
Via
Benzinga
Twist Bioscience to Report Fiscal 2022 Fourth Quarter and Full Year Financial Results on Friday, November 18, 2022
November 03, 2022
From
Twist Bioscience Corporation
Via
Business Wire
Twist Bioscience and Illumina Partner to Produce Robust Exome Panel to Advance Research
November 02, 2022
From
Twist Bioscience Corporation
Via
Business Wire
< Previous
1
2
...
6
7
8
9
10
11
12
13
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.